Soliton’s (NASDAQ:SOLY) lock-up period will expire on Monday, August 19th. Soliton had issued 2,172,591 shares in its IPO on February 19th. The total size of the offering was $10,862,955 based on an initial share price of $5.00. After the end of the company’s lock-up period, restrictions preventing company insiders and major shareholders from selling shares in the company will be lifted.
Shares of Soliton stock opened at $9.72 on Friday. The business has a 50-day simple moving average of $13.24. Soliton has a 52 week low of $4.12 and a 52 week high of $29.00.
A number of institutional investors have recently modified their holdings of SOLY. Vanguard Group Inc. bought a new stake in Soliton in the second quarter worth about $2,040,000. BlackRock Inc. bought a new stake in Soliton in the second quarter worth about $1,493,000. Northern Trust Corp bought a new stake in Soliton in the second quarter worth about $472,000. Jane Street Group LLC bought a new stake in Soliton in the second quarter worth about $417,000. Finally, National Asset Management Inc. bought a new stake in Soliton in the first quarter worth about $162,000. Hedge funds and other institutional investors own 0.56% of the company’s stock.
Soliton, Inc, an early stage medical device company, focuses on developing and commercializing products using a proprietary rapid acoustic pulse technology platform. It offers a device for the removal of tattoos. The company was founded in 2012 and is headquartered in Houston, Texas.
See Also: Google Finance Portfolio Workaround
Receive News & Ratings for Soliton Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Soliton and related companies with MarketBeat.com's FREE daily email newsletter.